BioGaia AB (publ) (STO:BIOG.B)
111.90
-0.80 (-0.71%)
Mar 25, 2026, 4:37 PM CET
BioGaia AB Revenue
In the year 2025, BioGaia AB had annual revenue of 1.54B SEK with 8.11% growth. BioGaia AB had revenue of 440.57M in the quarter ending December 31, 2025, with 20.76% growth.
Revenue
1.54B
Revenue Growth
+8.11%
P/S Ratio
7.41
Revenue / Employee
6.36M
Employees
242
Market Cap
11.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 115.45M | 8.11% |
| Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
| Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
| Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
| Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
| Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
| Dec 31, 2019 | 768.35M | 26.48M | 3.57% |
| Dec 31, 2018 | 741.87M | 126.87M | 20.63% |
| Dec 31, 2017 | 615.00M | 80.31M | 15.02% |
| Dec 31, 2016 | 534.70M | 51.46M | 10.65% |
| Dec 31, 2015 | 483.24M | 1.44M | 0.30% |
| Dec 31, 2014 | 481.80M | 165.93M | 52.53% |
| Dec 31, 2013 | 315.88M | -329.38M | -51.05% |
| Dec 31, 2012 | 645.25M | 330.26M | 104.85% |
| Dec 31, 2011 | 314.99M | 78.96M | 33.45% |
| Dec 31, 2010 | 236.03M | 32.57M | 16.01% |
| Dec 31, 2009 | 203.46M | 58.27M | 40.13% |
| Dec 31, 2008 | 145.19M | 38.61M | 36.23% |
| Dec 31, 2007 | 106.58M | 19.79M | 22.80% |
| Dec 31, 2006 | 86.79M | 27.19M | 45.61% |
| Dec 31, 2005 | 59.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 28.24B |
| EQL Pharma AB | 425.75M |
| Cinclus Pharma Holding AB | 57.47M |
| Nanexa AB | 55.94M |
| Enzymatica AB | 53.90M |
| Cereno Scientific AB | 44.27M |
| Orexo AB | 26.00M |
| Moberg Pharma AB | 13.54M |